Oct 18 2024
A new study from Georgia State University, published in the journal Drug and Alcohol Dependence, shows that there continues to be issues with misrepresentation of MDMA in unregulated markets across the United States, although there has been improvements in recent years. The research analyzed 4,719 alleged MDMA samples submitted to the DrugsData drug-checking service, aiming …
Oct 18 2024
A study set to be published in the journal Archives of Oral Biology in January 2025 explores the potential biological effects of cannabidiol (CBD) on oral squamous cell carcinoma cells. Conducted by researchers from the University of Perugia in Italy, the study examines CBD as a possible adjuvant therapy in cancer treatment. The study was …
Oct 18 2024
The global cannabis testing services market size is expected to reach $5.39 billion by 2030, registering a compound annual growth rate (CAGR) of 17.21% from 2024 to 2030, according to a new report. Conducted by Research and Markets, the report shows that the current value of the cannabis testing market is $2.1 billion, an increase …
Oct 18 2024
A recent study published in the Canadian Journal of Microbiology demonstrates that the cannabis compound cannabidiol (CBD) may effectively inhibit the growth of Candida albicans, a yeast commonly associated with infections such as oral candidiasis. Researchers treated C. albicans with varying concentrations of CBD, ranging from 0 to 20 µg/mL, and observed a significant reduction …
Oct 17 2024
The Washington D.C. Council has passed the Medical Cannabis Clarification Amendment Act (Council Bill 25-581), a notable update to the District’s medical cannabis framework. The bill, approved by the full council earlier this month, was officially presented to Mayor Muriel Bowser’s today. Mayor Bowser now faces a deadline of October 31 to either sign it into …
Oct 17 2024
An early economic analysis published in the journal Expert Review of Pharmacoeconomics & Outcomes Research suggests that medical marijuana could provide notable cost savings when treating chronic pain. The study assessed the cost-effectiveness of cannabis-based medicinal products (CBMPs) compared to other treatment options, such as analgesics, physiotherapy, and cognitive behavioral therapy, over a one-year period …
Oct 17 2024
The New Jersey Department of State’s New Jersey Business Action Center (NJBAC), with designation and support from the New Jersey Cannabis Regulatory Commission (CRC), has launched the Cannabis Training Academy (CTA). The CTA was officially launched yesterday, October 16. This no-cost, online cannabis educational platform aids and educates current and aspiring cannabis business owners as …
Oct 17 2024
Medical marijuana sales in Germany are projected to surpass €420 million (about $455.2 million) in 2024, with the market on track to hit €1 billion by 2028, according to the German Cannabis Report from Prohibition Partners, a London-based data firm. The report highlights a 30% rise in medical marijuana sales in state-licensed pharmacies during the …
Oct 17 2024
Michigan’s full Senate has approved Senate Bill 807 through its second reading. Filed by Senator Sean McCann in April, Senate Bill 807 was approved yesterday by the full Senate. This vote allows the measure to advance to a third and final reading. The vote comes roughly a month after the measure was passed through the …
Oct 17 2024
In September, Illinois saw marijuana sales above $150 million for the 12th consecutive month. According to updated numbers provided by the Illinois Cannabis Regulation Oversight Officer, there was $136.5 worth of recreational marijuana sold in September, in addition to $21.7 million worth of medical marijuana. The combined $158.2 million is a noticable dip from the …
